Supravenous hyperpigmentation induced by vinorelbine.
Cecchi
R
R
Tuci
F
F
Giomi
A
A
Innocenti
F
F
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D005542:Forearm; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D007275:Injections, Intravenous; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D014747:Vinblastine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077235:Vinorelbine
D000970:Antineoplastic Agents; D014747:Vinblastine; D000077235:Vinorelbine